CN Patent

CN107126419B — 一种奥贝胆酸片剂及其制备方法

Assigned to Shijiazhuang Pharma Group Zhongnuo Pharmaceutical Shijiazhuang Co Ltd · Expires 2020-06-19 · 6y expired

What this patent protects

本发明涉及一种奥贝胆酸片及其制备方法，属于医药技术领域。所述奥贝胆酸片采用固体分散技术，处方中选用了醋酸羟丙甲纤维素琥珀酸酯、聚乙二醇6000、低取代羟丙纤维素、交联聚乙烯吡咯烷酮。本发明将奥贝胆酸制成固体分散体再与辅料压片，克服了原料流动性差、静电大、原辅料不易混合均匀，且原料粘纸粘袋严重等问题，所得奥贝胆酸片安全、有效、质量可控。

USPTO Abstract

本发明涉及一种奥贝胆酸片及其制备方法，属于医药技术领域。所述奥贝胆酸片采用固体分散技术，处方中选用了醋酸羟丙甲纤维素琥珀酸酯、聚乙二醇6000、低取代羟丙纤维素、交联聚乙烯吡咯烷酮。本发明将奥贝胆酸制成固体分散体再与辅料压片，克服了原料流动性差、静电大、原辅料不易混合均匀，且原料粘纸粘袋严重等问题，所得奥贝胆酸片安全、有效、质量可控。

Drugs covered by this patent

Patent Metadata

Patent number
CN107126419B
Jurisdiction
CN
Classification
—
Expires
2020-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Shijiazhuang Pharma Group Zhongnuo Pharmaceutical Shijiazhuang Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.